Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 92


Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses.

Shen D, Chang HR, Chen Z, He J, Lonsberry V, Elshimali Y, Chia D, Seligson D, Goodglick L, Nelson SF, Gornbein JA.

Biochem Biophys Res Commun. 2005 Jan 7;326(1):218-27.


In silico identification of breast cancer genes by combined multiple high throughput analyses.

Shen D, He J, Chang HR.

Int J Mol Med. 2005 Feb;15(2):205-12.


Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.

Ou K, Yu K, Kesuma D, Hooi M, Huang N, Chen W, Lee SY, Goh XP, Tan LK, Liu J, Soon SY, Bin Abdul Rashid S, Putti TC, Jikuya H, Ichikawa T, Nishimura O, Salto-Tellez M, Tan P.

J Proteome Res. 2008 Apr;7(4):1518-28. doi: 10.1021/pr700820g. Epub 2008 Mar 5.


Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis.

Shen D, Nooraie F, Elshimali Y, Lonsberry V, He J, Bose S, Chia D, Seligson D, Chang HR, Goodglick L.

Hum Pathol. 2006 Dec;37(12):1583-91. Epub 2006 Aug 10.


Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.

Sørlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, Børresen-Dale AL.

BMC Genomics. 2006 May 26;7:127.


[Identification of gastric cancer-related genes by multiple high throughput analysis and data mining].

Meng LX, Li Q, Xue YJ, Guo RD, Zhang YQ, Song XY.

Zhonghua Wei Chang Wai Ke Za Zhi. 2007 Mar;10(2):169-72. Chinese.


MMP13 is potentially a new tumor marker for breast cancer diagnosis.

Chang HJ, Yang MJ, Yang YH, Hou MF, Hsueh EJ, Lin SR.

Oncol Rep. 2009 Nov;22(5):1119-27.


Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.

Van Laere SJ, Van den Eynden GG, Van der Auwera I, Vandenberghe M, van Dam P, Van Marck EA, van Golen KL, Vermeulen PB, Dirix LY.

Breast Cancer Res Treat. 2006 Feb;95(3):243-55. Epub 2005 Oct 27.


Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.

Urban P, Vuaroqueaux V, Labuhn M, Delorenzi M, Wirapati P, Wight E, Senn HJ, Benz C, Eppenberger U, Eppenberger-Castori S.

J Clin Oncol. 2006 Sep 10;24(26):4245-53.


Profile of differentially expressed genes after transfer of chromosome 17 into the breast cancer cell line CAL51.

Klebig C, Seitz S, Korsching E, Kristiansen G, Gustavus D, Scherneck S, Petersen I.

Genes Chromosomes Cancer. 2005 Nov;44(3):233-46.


Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells.

Kim JM, Sohn HY, Yoon SY, Oh JH, Yang JO, Kim JH, Song KS, Rho SM, Yoo HS, Kim YS, Kim JG, Kim NS.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):473-82. Erratum in: Clin Cancer Res. 2005 Apr 15;11(8):3149. Yoo, Hyan Sook [corrected to Yoo, Hyang-Sook].


Cross platform microarray analysis for robust identification of differentially expressed genes.

Bosotti R, Locatelli G, Healy S, Scacheri E, Sartori L, Mercurio C, Calogero R, Isacchi A.

BMC Bioinformatics. 2007 Mar 8;8 Suppl 1:S5.


Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.

Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van Marck EA, van Dam P, Vermeulen PB, Dirix LY, van Golen KL.

Breast Cancer Res Treat. 2006 Feb;95(3):219-28. Epub 2005 Oct 22.


A resampling-based meta-analysis for detection of differential gene expression in breast cancer.

Gur-Dedeoglu B, Konu O, Kir S, Ozturk AR, Bozkurt B, Ergul G, Yulug IG.

BMC Cancer. 2008 Dec 30;8:396. doi: 10.1186/1471-2407-8-396.


A supervised approach for identifying discriminating genotype patterns and its application to breast cancer data.

Yosef N, Yakhini Z, Tsalenko A, Kristensen V, Børresen-Dale AL, Ruppin E, Sharan R.

Bioinformatics. 2007 Jan 15;23(2):e91-8.


High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.

Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, Robertson JF, Macmillan D, Blamey RW, Ellis IO.

Int J Cancer. 2005 Sep 1;116(3):340-50.


CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer.

O'Brien SL, Fagan A, Fox EJ, Millikan RC, Culhane AC, Brennan DJ, McCann AH, Hegarty S, Moyna S, Duffy MJ, Higgins DG, Jirström K, Landberg G, Gallagher WM.

Int J Cancer. 2007 Apr 1;120(7):1434-43.


Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers.

Smalley MJ, Iravani M, Leao M, Grigoriadis A, Kendrick H, Dexter T, Fenwick K, Regan JL, Britt K, McDonald S, Lord CJ, Mackay A, Ashworth A.

Breast Cancer Res. 2007;9(6):R85.


Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression.

Yao J, Weremowicz S, Feng B, Gentleman RC, Marks JR, Gelman R, Brennan C, Polyak K.

Cancer Res. 2006 Apr 15;66(8):4065-78.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk